Feb 28 (Reuters) - Dyadic International Inc DYAI.O :
* DYADIC ANNOUNCES STRATEGIC PARTNERSHIP AGREEMENT TO
DEVELOP AFFORDABLE RABIES PROPHYLACTICS AND VACCINES USING ITS
PROPRIETARY C1 CELL MICROBIAL PROTEIN PRODUCTION PLATFORM
* DYADIC INTERNATIONAL INC - DUTCH SUBSIDIARY, DYADIC
NEDERLAND
BV HAS ENTERED INTO A STRATEGIC PARTNERSHIP AGREEMENT AND
COLLABORATION WITH RABIAN BV
* DYADIC INTERNATIONAL INC: DYADIC NEDERLAND BV HAS ENTERED
INTO A
STRATEGIC PARTNERSHIP AGREEMENT AND COLLABORATION WITH RABIAN BV
* DYADIC INTERNATIONAL INC - RABIAN WILL USE TOTAL FUNDING
OF
ABOUT Є 1.7 MILLION TO DEVELOP A RABIES VACCINE USING DYADIC'S
C1 PROTEIN PRODUCTION PLATFORM
* DYADIC INTERNATIONAL: DYADIC TO GET EQUITY STAKE IN, FULLY
FUNDED RESEARCH, DEVELOPMENT COSTS, SPECIFIED PRODUCT MILESTONES
AND ROYALTIES
Source text for Eikon: ID:nGNXLVdYC
Further company coverage: DYAI.O
((Reuters.Briefs@thomsonreuters.com;))